Current trends in Nuclear Cardiology virtual event hosted by the BIR in association with American Society of Nuclear Cardiology (ASNC)

3rd June 2021 14:00 - 17:40 (GMT+01:00) Europe/London

Virtual event – Thursday 3 June 14:00-17:40 BST
CPD Credits: 3 RCR points
Free to register!

Welcome to the first joint BIR/ASNC Nuclear Cardiology Clinical Update 2021! This half-day virtual event will cover the existing and new exciting applications in the fields of PET myocardial perfusion, infection and inflammation imaging as well as SPECT in CAD and amyloidosis. Our renowned international multidisciplinary faculty of expert imaging cardiologists and nuclear medicine physicians will provide a comprehensive overview of radionuclide PET and SPECT imaging in various cardiovascular diseases. Attendees will be able to appreciate the strengths and understand the appropriate use of cardiovascular radionuclide imaging.

This virtual event will be of interest to all nuclear medicine physicians; radiologists and cardiologists with special interest in imaging; trainees, clinical physicists, technologists and healthcare managers.

View virtual programme here

Educational aims:

To understand the appropriate guidelines-based use of nuclear cardiology imaging for patients with known or suspected CAD using SPECT and PET.
To understand the appropriate guidelines-based use of nuclear cardiology imaging for patients with suspected cardiac infection/inflammation and cardiac amyloidosis.
At the conclusion of the webinar, the participant will have a better understanding of the role of nuclear cardiology in various clinical settings.

Registration instructions
In order to register for this event you must first create a MyBIR portal. This is a free account with the BIR which will allow you to register for events and to retrieve receipts and CPD certificates. Once this is created, you can then register onto the event. If you have registered for a BIR event in the past you can login to your account first and then click on the register now button. You do not need to be a member of BIR or a radiologist to register for this event. All healthcare professionals are welcome. If you are having any issues registering please email conference@bir.org.uk

If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email conference@bir.org.uk

Please ensure that you have read the events terms and conditions here, before booking onto an event.

Venue

Speakers

Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Bayer

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

Bracco UK Ltd

Curium Pharma UK Ltd

GE Healthcare Ltd

GE Healthcare is a manufacturer and distributor of both diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures as well as medical diagnostic equipment including CT image machines. Further, we develop health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. As a leading global medical technology, diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the centre of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. We embrace a culture of respect, transparency, integrity and diversity.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

Siemens Healthineers is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. For more information and latest product line visit www.siemens-healthineers.co.uk